609 studies found for:    (pregnancy OR maternal) AND (acquired immunodeficiency syndrome)
Show Display Options
RSS Create an RSS feed from your search for:
(pregnancy OR maternal) AND (acquired immunodeficiency syndrome)
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: HIV immune globulin solution
2 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
3 Completed Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
Condition: Human Immunodeficiency Virus
Intervention:
4 Completed Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy
Conditions: Male Partner;   HIV Counseling and Testing;   Home Based;   Pregnancy
Intervention: Other: HIV counseling and testing
5 Recruiting Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe
Condition: HIV Infection
Intervention: Behavioral: Mother support groups for HIV+ mothers
6 Completed Daily Nevirapine to Prevent Mother to Infant Transmission of HIV
Condition: HIV Infections
Intervention: Drug: Nevirapine and mulitvitamins
7 Terminated Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Maternal and infant nevirapine;   Drug: Maternal placebo and infant nevirapine;   Drug: Maternal lopinavir+ritonavir;   Drug: zidovudine
8 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
9 Active, not recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
10 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
11 Completed Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
Condition: HIV
Interventions: Other: HIV testing commodity reinforcement;   Other: Policy reinforcement meeting;   Other: Opt-out HIV testing for mothers and newborns;   Other: Operational support for service integration;   Other: Community sensitization
12 Active, not recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
13 Completed
Has Results
Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Pregnancy
Interventions: Behavioral: HIV, STD, and pregnancy prevention curriculum;   Behavioral: Standard sexual education curriculum
14 Completed Breastfeeding, Antiretroviral, and Nutrition Study
Condition: HIV Infections
Interventions: Drug: Maternal zidovudine/lamivudine/lopinavir-ritonavir;   Drug: Infant nevirapine;   Dietary Supplement: Maternal protein and calorie supplement
15 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
16 Completed Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program
Conditions: HIV;   Sexually Transmitted Diseases;   Pregnancy;   HIV Infections
Intervention: Behavioral: HIV, STD, Pregnancy Prevention Curriculum
17 Completed A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Anti-HIV Immune Serum Globulin (Human);   Drug: Globulin, Immune;   Drug: Zidovudine
18 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention
19 Completed Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: ZDV Short (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Short (mother)-Long (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Long (infant): Comparison of zidovudine durations
20 Completed Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: Cotrimoxazole prophylaxis;   Drug: SP IPT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years